Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private

BSE1988.5590.05 (+4.74 %)

PREV CLOSE ( ) 1898.50

OPEN PRICE ( ) 1898.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 11304

TODAY'S LOW / HIGH ( )1898.50 2020.00

52 WK LOW / HIGH ( )1206 2658

NSE1991.2090.3 (+4.75 %)

PREV CLOSE( ) 1900.90

OPEN PRICE ( ) 1905.95

BID PRICE (QTY) 1991.20 (33)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 396104

TODAY'S LOW / HIGH( ) 1905.00 2019.00

52 WK LOW / HIGH ( )1205.45 2664

Chairman	Sudhir Vaid
Managing Director	Sudhir Vaid
Company Secretary	Prakash Sajnani
Non Executive Director	Ravi Kapoor Rajiv Agarwal
Joint Managing Director	Ankur Vaid
Independent Non-Executive Director	Arvind Agarwal Bharti Khanna Amitabh Thakore Jayaram Easwaran Mandayam Chakravarthy Sriraman

Incorporation Year : 1984

Registered Office :

Address : 1482-1486 ,Trasad Road,Dholka Ahmedabad Dist,
Gujarat-382225 .

Phone : 02714-222604 / 398200

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE